ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0803

Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis

Juan Carlos Cortés-Quiroz1, Javier Ena2, José Antonio Bernal3 and José Rosas4, 1Marina Baixa Hospital, Mutxamel, Spain, 2Department of Internal Medicine. Marina Baixa Hospital, Villajoyosa, Spain, 3Rheumatology Department. Marina Baixa Hospital, Alicante, Spain, 4Rheumatology Department, Hospital Marina Baixa, Villajoyosa, Spain

Meeting: ACR Convergence 2022

Keywords: Arthritis, Infectious, Joint Structure, Measurement Instrument, meta-analysis, Synovitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Adenosine deaminase (ADA) activity has shown good performance in diagnosing pleural, peritoneal, and meningeal tuberculosis. This study aimed to evaluate the performance of measuring ADA activity in synovial fluid for the early diagnosis of joint tuberculosis.

Methods: We performed a meta-analysis to determine the performance of ADA measured in synovial fluid for the diagnosis of joint tuberculosis. We searched published information in MEDLINE, Embase, Cochrane Library, Web of Science, and MedRxiv databases, as well as unpublished information in the American College of Rheumatology and European League

Against Rheumatism for conference abstracts (2012-2021). We also scanned the reference lists of articles. Two reviewers independently applied the criteria for selection, assessed quality, and extracted data.

Results: Seven independent studies (N= 305 subjects) that compared ADA activity in synovial fluid with a composite reference diagnostic method for tuberculosis were included. Overall, the risk of bias was judged low. Studies were classified as high quality (n=3; 148 subjects) and low quality (n= 4; 157 subjects). The cut-off values of ADA for diagnosing tuberculosis ranged from 15 to 60 IU/L, being the median value between 40-50 IUL/L.

Pooled sensitivity and specificity of ADA activity was 94% (95% confidence interval [CI], 0.89-98; I2=23%) and 88% (95% CI, 83-92; I2= 83%), respectively. The random-effects model for pooled diagnostic Odds ratio was 67.1 (95%CI, 20.3-222.2; I2=30%). The area under the receiver operating characteristic curve was 0.96 (95% CI, 0.92-0.99). Metaregression did not identify the quality of the study, country of publication, or the type of assay as a source of heterogeneity.

Conclusion: In summary, measuring the activity of adenosine deaminase in synovial fluid is easy, cheap, and available in areas with poor resources. Adenosine deaminase activity values above the cutoff point add significant diagnostic information to start empirical treatment against tuberculosis while waiting for synovial fluid Lowenstein culture results. Adenosine deaminase activity in synovial fluid can be used as an additional tool for the diagnosis of tuberculosis joint infection in cases of negative results from nucleic acid amplification methods.

Supporting image 1

Supporting image 2

Figure 4. Area under the Receiver Operating Characteristic of synovial ADA for tuberculous

Supporting image 3

Figure 3: Pooled sensitivity and specificity


Disclosures: J. Cortés-Quiroz, None; J. Ena, None; J. Bernal, None; J. Rosas, None.

To cite this abstract in AMA style:

Cortés-Quiroz J, Ena J, Bernal J, Rosas J. Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/performance-of-adenosine-deaminase-activity-in-sinovial-fluid-for-the-early-diagnosis-of-tuberculous-arthritis-a-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-adenosine-deaminase-activity-in-sinovial-fluid-for-the-early-diagnosis-of-tuberculous-arthritis-a-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology